Federated Hermes
ATNM icon

Federated Hermes’s Actinium Pharmaceuticals ATNM Stock Holding History

Federated Hermes’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.4K Hold
1,403
– – ﹤0.01% 1989
2025
Q4 		$1.91K Sell
1,403
-522
-27% -$762 ﹤0.01% 1969
2025
Q3 		$3.08K Sell
1,925
-3,396
-64% -$5.53K ﹤0.01% 1989
2025
Q2 		$7.45K Sell
5,321
-218
-4% -$326 ﹤0.01% 1853
2025
Q1 		$8.92K Buy
5,539
+2,796
+102% +$3.55K ﹤0.01% 1824
2024
Q4 		$3.46K Buy
2,743
+743
+37% +$1.15K ﹤0.01% 1928
2024
Q3 		$3.76K Buy
+2,000
New +$7.9K ﹤0.01% 1888

Other funds holding ATNM

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes's ATNM Position: Q1 2026 in Review

Federated Hermes held its Actinium Pharmaceuticals (ATNM) position steady in Q1 2026 at 1,403 shares worth $1.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.

Federated Hermes first reported a position in ATNM in Q3 2024 and has held it in 7 quarters since. The position peaked at $8.92K in Q1 2025. 54 funds tracked by Wall St. Rank hold ATNM as of Q1 2026.

  • Federated Hermes held 1,403 shares of Actinium Pharmaceuticals worth $1.4K as of Q1 2026.
  • Federated Hermes left its Actinium Pharmaceuticals share count unchanged in Q1 2026.
  • Actinium Pharmaceuticals made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1989 holding.
  • Federated Hermes first reported a position in Actinium Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Federated Hermes's Actinium Pharmaceuticals position peaked at $8.92K in Q1 2025.
  • 54 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.